DNDi logo

Search Results

filter by

1999 — 2021

Chagas: new study puts researchers closer to shortening the length of treatment

A clinical trial has been launched in Argentina to see if a shorter regimen of the drug benznidazole has the potential to become a new standard treatment for Chagas disease to treat adult patients in the chronic phase of the disease, with fewer side effects.

A new study is underway to confirm the effectiveness of a shorter treatment for Chagas disease, with fewer side effects

  • Press releases
Two woman discussing in hospital setting

Chagas: new study puts researchers closer to shortening the length of treatment

A clinical trial has been launched in Argentina to see if a shorter regimen of the drug benznidazole has the potential to become a new standard treatment for Chagas disease to treat adult patients in the chronic phase of the disease, with fewer side effects.

A new study is underway to confirm the effectiveness of a shorter treatment for Chagas disease, with fewer side effects

  • Press releases
Two woman discussing in hospital setting

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform

PLOS Neglected Tropical Diseases

  • Scientific articles

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform

  • Scientific articles

GHIT Fund renews support for DNDi drug discovery and early-stage development for leishmaniasis and Chagas disease

GHIT Fund will provide a total of JPY 955 million (EUR 7.4 million) in additional funding for four projects over the 2021-2023 period, each underpinned by vital collaborations between DNDi and its Japanese R&D partners.

Additional JPY 955 million (EUR 7.4 million) in funding will support work to advance urgently needed medical innovation for millions of people affected by the two neglected tropical diseases

  • Press releases
Lab equipment

GHIT Fund renews support for DNDi drug discovery and early-stage development for leishmaniasis and Chagas disease

GHIT Fund will provide a total of JPY 955 million (EUR 7.4 million) in additional funding for four projects over the 2021-2023 period, each underpinned by vital collaborations between DNDi and its Japanese R&D partners.

Additional JPY 955 million (EUR 7.4 million) in funding will support work to advance urgently needed medical innovation for millions of people affected by the two neglected tropical diseases

  • Press releases
Lab equipment

Unitaid and the Brazilian Ministry of Health announce initiative to fight congenital Chagas disease

The project is aimed at four countries in Latin America. It is the first time that the global health agency Unitaid has mobilized resources for Chagas.

  • News
Mother breastfeeding her baby

Unitaid and the Brazilian Ministry of Health announce initiative to fight congenital Chagas disease

The project is aimed at four countries in Latin America. It is the first time that the global health agency Unitaid has mobilized resources for Chagas.

  • News
Mother breastfeeding her baby

Please select a search term or criteria.

loading
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

Get in touch

Support us

Work with us